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Evaluation of anxiety
and depression incidence
in adolescents with cystic
fibrosis or malignant diseases
Abstract
Background. Malignant diseases and cystic fibrosis are responsible for long-lasting states of frustration and
suffering, which particularly affect adolescents. Considering potentially dangerous effects of anxiety and
depressive episodes, prompt and reliable diagnosis and therapy become especially important for both
quality of life and its preservation. Problems with the evaluation of incidence of anxiety and widely under-
stood depression, and contradictory results found in literature, encouraged researchers to attempt the
assessment of incidence of chosen negative emotions in adolescents.
Material and methods. The study group comprised of adolescents and young adults, aged from 14 to 21,
hospitalised because of malignant diseases (n = 78; group I) and cystic fibrosis (n = 53; group II). The
incidence of anxiety and depression was evaluated with the Hospital Anxiety and Depression Scale (HADS).
Results. Anxiety was observed in 25% of CF patients and 14% of cancer patients whereas depression was
diagnosed in 10% of group I patients and 6% of group II respondents. The study groups showed no
difference in the level of anxiety and depression (p ‡ 0.05). No statistically significant correlations between
patients groups, divided in regard to the level of anxiety and depression, were found (Ch2 = 2.4, p = 0.3 vs.
Ch2 = 1.04, p = 0.59). The multivariate analysis (ANOVA) also confirmed that anxiety and depression
incidence did not depend on diagnosis (R Rao = 1.5, p = 0.23). Both groups showed strong positive relation
between the level of anxiety and depression (r = 0.66, p = 0.001).
Conclusions. The level of anxiety and depression was observed in a small proportion of respondents.
Adolescents suffering from CF and malignant diseases showed no difference in regard to the anxiety and
depression levels. However, it could be possible that patients hid disturbing symptoms (anxiety and depres-
sion). Therefore, special care must be delivered to those whose level of depression and anxiety are close to
the upper norm limit.
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Introduction
Adolescence (i.e. according to the WHO, age from
14 to 21 years) is a period of significant physiological
and psychological changes, characterised by a mean-
ingful fluctuation of mood and emotions. There is a
huge need for psychic comfort so a young person
may become independent, find acceptance among
peers, face the future and make serious decisions
about education, career and life targets [1, 2].
The chronicity and unpredictability of malignant
diseases and fatal course of cystic fibrosis (CF) may
prevent young people from fulfilling social roles, but
it also may encourage negative emotions. These neg-
ative emotions increase suffering and radically de-
crease patients quality of life through making ado-
lescents vulnerable to their disease [3]. Meanwhile,
the incidence of negative emotions of depressive char-
acter or fear may determine young persons sense of
life and purpose [4, 5]. The sense of life becomes
especially meaningful for adolescents due to accom-
plishing the milestones specific for this age.
Anxiety is a signal of a threat in the psychic sphere
and after finding a way to human consciousness it
affects ones behavior. Young patients with chronic
anxiety become more vulnerable to high level of
emotional distress. Mental discomfort is magnified
by many limitations experienced by adolescents with
malignant diseases or CF e.g. limitations of physical
activity, periods of extreme fatigue, pain and depri-
vation of many needs [1, 3, 6]. The power of anxiety
influence on humans development significantly in-
creases in adolescence. Young people may also ex-
perience problems concerning planning their future
when disease relapses occur and prognosis is uncer-
tain (malignant diseases) or, especially when the
life-long prognosis is fatal (CF), and their disease is
connected with re-hospitalization and separation
from the closest [68].
Depression is mostly the consequence, threaten-
ing most adolescents with cancer or CF. The expres-
sion depressive syndrome or depression has var-
ious meanings. It is commonly used to describe short
states of worsened mood or discouragement or even
decreased well-being. But it also may describe
mental disease by itself, with extremely serious psy-
chotic symptoms. The most frequent mistake is made
when commonly understood depression is con-
fused with organic depression, meaning disease syn-
drome where worsened mood is only one of many
symptoms [9]. This way it may cause numerous con-
fusions in diagnostic process, when varying organic
depression from the depressive state symptoms of
fatigue, frustration or decreased emotional status
due to many stressful circumstances [10]. In chronic
and severely ill patients, even depressive behavior
stays undiagnosed and untreated because of com-
mon believe that depressive attitude always ac-
company the fatal disease and is universal reaction
to a serious disease. Very often neurovegetative
symptoms like weigh lost, sleep disorders or emo-
tional depressive disorders are perceived as cancer
symptoms [11]. The more complicated situation is
to be observed in patients with CF.
In consideration of potentially dangerous effects
of anxiety and depressive episodes, prompt and reli-
able diagnosis and adequate therapy seem to be ex-
tremely important in both aspects: quality of life and
its preservation. Prolong anxiety, but especially the
course of depression, not only complicates adjust-
ment to the disease and its therapy, but also affects
endocrine and immunologic functions [12, 13].
Failure in overcoming physiological problems re-
lated to adolescence, often characterized by depres-
sive behavior, as well as fatal disease-oriented chronic
anxiety and depression, may disturb the process of
establishing competences and leaving young per-
son vulnerable to further depressive episodes, which
were pointed out by Evans [14] and Tebbi [15]. The
diversity of anxiety presentations and its prevalence
must encourage the therapeutic team to find the
source and discharge anxiety-forming situations.
Purpose
The purpose of this work was to evaluate the
incidence of negative emotions (depressive charac-
ter and anxiety) in adolescents hospitalized due to
CF or malignant disease. The following research thesis
was formed in relation to the general purpose:
1. Is there any anxiety or depressive behavior ob-
served in the studied groups?
2. Does the level of depressive behavior and anxi-
ety differ between the studied groups and does
it depend on diagnosis?
3. Is there a relationship between anxiety and de-
pression within each group and in both groups
together?
Material and methods
The study included 131 young males and females,
aged from 14 to 21. Among them, 78 suffered from
cancer (group I) and 53 (group II) were CF patients
(Table 1) The study included patients with CF and
malignant diseases because of their common fea-
tures i.e. disease chronicity, threat of premature
death (in CF patients death is inevitable), painful
and burdensome therapy and diagnostics, frequent
www.advpm.eu 77
Gra¿yna Cepuch et al., Adolescents with cystic fibrosis or malignant diseases
and long hospitalisations and worse social contacts
(e.g. individual education).
In order to conduct the study among adoles-
cents with oncological diseases, the consent of the
Bioethical Committee, Jagiellonian University (KBET/
395/B/2003) was obtained and the Scientific Research
Committee by the Institute of Tuberculosis and Pul-
monary Diseases in Warsaw (KE-29/2004) approved
the study concerning CF patients.
Written consent signed by the participant and
his/her legal guardian was the vital condition of in-
clusion in the study. The study involved patients with
leukaemia, lymphomas, bone tumours and soft tis-
sue sarcomas, as well as patients with cystic fibrosis,
proofed by biochemical sweat test and DNA analysis.
Patients qualified for this study were in different
stages of diseases. However, patients with very ad-
vanced and terminal illness were excluded because
of ethical reasons. Adolescents with acute exacer-
bations of cystic fibrosis and patients with coexist-
ing diseases and disorders of other organs and sys-
tems, which may cause more negative emotions,
were excluded from the study.
Research methods included medical record anal-
ysis, survey questionnaire and the Hospital Anxiety
and Depression Scale (HADS), which is a tool for the
evaluation of anxiety level and depression intensity
in the population of patients with somatic not psy-
chiatric disorders. The HADS may be used as a screen-
ing tool not only by psychologists but also by other
members of the therapeutic team. The HADS scale is
believed to be a reliable and apt method for the
assessment of negative emotions. Despite the fact
that this scale was meant for adult patients, it may
be successfully used in the group of adolescents
without any decrease in its aptness and reliability
[1621]. In authors research the evaluation of neg-
ative emotions incidence (i.e. anxiety and depres-
sion) was given with mean raw data. The data range
was between 0 and 21. Results were interpreted
with the scale of anxiety and depression using three
categories: no disorder (07 points), borderline
status (810 points) and presence of disorder
(1121 points).
Obtained results were analysed with the Mann-
Whitney U test, Chi-Square Independence Test, [R]
Pearsons correlation coefficient and multivariate
analysis of variance Anova (Manova).
Results
The evaluation of negative emotions (anxiety,
depression) incidence in the studied group was pre-
sented with the mean values of raw data i.e. the
sum of points in a given scale, and then categorised.
The mean score for anxiety in group I was 6.68 –
4.60 and in group II  7.3 – 4.04. For depression
those scores equalled 4.35 – 3.85 and 4.10 – 3.65
in group I and II, respectively. Statistical analysis
showed that the mean values of anxiety and depres-
sive disorders intensity didnt significantly differ be-
tween those groups (p = 0.23 in group I and p =
0.73 in group II). (Fig. 1).
Evaluation results of anxiety and depressive dis-
orders were grouped into three categories: no dis-
orders, borderline, and presence of disorders. Table
2 and 3 show percentage distribution of those re-
sults. Anxiety disorders were observed in 14% of
cancer patients and 25% of CF patients, while de-
pressive symptoms were found in 10% and 25%
of corresponding groups. Statistical analysis didnt
Table 1. Demographic characteristics of the
studied groups
Groups n Aged Sex
x SD Min Max Female Male
Group I
(cancer) 78 16.6 1.4 14 20 35 (42.7%) 47 (57.3%)
Group II
(cystic 53 18.7 2.5 14 21 28 (52.8%) 25 (47.2%)
fibrosis)
Table 2. Assessment of fear occurence in examined
groups with Hospital Anxiety and Depression Scale
Groups Anxiety
Lack of disorders Borderline Disorders
Group I 45 (57%) 23 (29%) 11 (14%)
(n = 78)
Group II 25 (47%) 15 (28%) 13 (25%)
(n=53)
Significance NS
of differences
Ch2 (n = 131, df = 2) = 2.40, p = 0.30; NS  no significant
Figure 1. Mean values of anxiety and depression level
(mean values were given with mean error)
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Strong positive correlation was proven be-
tween the level of anxiety and depression in each
of the studied groups (Fig. 2, 3). Similar correlation
was observed while analysing both groups together
(r = 0.658, p < 0.001).
No statistically significant relation between the
incidence of anxiety and/or depression and the type
of disease (inclusion to a studied group) was found
while assessing connections between the incidence
of negative emotions and the fact of belonging to
a given group of patients (Fig. 4).
Patients were qualified to age subgroups within
the studied samples (CF and malignant disease) be-
cause the range of respondents age was wide. It was
assessed whether there is a relation between belong-
ing to an age group and anxiety and depression oc-
currence. Statistical analysis showed no such connec-
tion (Table 4). However, it must be noticed that ma-
lignant disease group comprised only of 12 patients
18 years old and older (15.4%) while CF group con-
sisted of 35 young adults at the age of 18 and more
(66%), which might have affected our results. No
analysis of negative emotions occurrence vs. gender
was performed because of too small study group.
Presented result must be treated as a preliminary
report due to the fact of generalisation and shall
become a subject for future complex research.
Discussion
Negative emotions accompanying the disease are
something quite natural and included in the ways of
managing the illness. Therefore, it is important not
only to find out whether they occur but also how
they are expressed, how strong they are and wheth-
er they affect patients quality of life.
Table 3. Assessment of depression occurence in
examined groups with Hospital Anxiety and
Depression Scale
Groups Depression
Lack of disorders Borderline Disorders
Group I 63 (80%) 8 (10%) 8 (10%)
(n = 78)
Group II 43 (81%) 7 (13%) 3 (6%)
(n = 53)
Significance NS
of differences
Ch2 (n = 131, df = 2) = 1.40, p = 0.59; NS  no significant
Figure 4. Dependency between anxiety and
depression level and belonging to the study group
(range of scale was limited to 10)
Figure 3. Correlation between anxiety and depression
for group I (cancer)
Figure 2. Correlation between anxiety and depression
for group II (group cystic fibrosis)
reveal any significant corelation between separated
evaluation categories of anxiety and depressive dis-
orders and the diagnosis (cystic fibrosis, malignant
diseases).
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This study showed that both anxiety and depres-
sion were observed in a small group of adolescent
patients with CF, and those with malignant diseas-
es. These results are consistent with outcomes pre-
sented by Kellerman et al. [22], Zeltzer et al. [23], or
Tebbi [15], Canning et al. [24] and Allen et al. [25].
All of the abovementioned authors showed that lev-
els of anxiety and depression observed in adoles-
cents with diagnosed malignant diseases werent
higher than those noted in the general population
of teenagers. Similarly, Trask et al. [26] indicated
that young patients experience minimal level of
emotional suffering in different stages of the dis-
ease. As far as CF patients are concerned, most stud-
ies show that their emotional problems dont vary
from those observed in healthy people, and are the
same or even smaller than the problems of patients
with other chronic diseases [1, 27].
However, it must be underlined that young pa-
tients in bad health condition or terminal disease
were not included in any of abovementioned stud-
ies. The authors would like to emphasize that this
group of adolescent patients may experience signif-
icantly stronger suffering. Therefore, in order to draw
final conclusions further research in this group of
patients must be done.
The study concerned cancer and CF adolescent
patients but it didnt assess other variables, which
may significantly affect final results e.g. family func-
tioning, educational achievements etc.
In addition, no relation between the incidence of
negative emotions in adolescents and the type of
diagnosed disease was found. Von Essen et al. [28]
presented similar results. His research also showed
that depression wasnt directly related to the diag-
nosis itself but rather to discomfort accompanying
a chronic disease e.g. pain. This is consistent with
other publications stating that negative emotions
predispose patients towards higher perception of
pain, on one hand but on the other one, continuous
pain in its effect may influence the incidence of
negative emotions and fatigue [29, 30]. Finaly, it
leads to what Wade and Price [31] called suffering.
Analysed publications ignored the problem of pain
in CF patients assuming it to be an unspecific symp-
tom. However, clinical practice suggests that pain in
this group of patients may accompany osteoporo-
sis, spinal curvature, arthritis, sinusitis, emphysema
and complications in the alimentary tract [32].
The level of obtained information on patients
health status is one of the important factors affect-
ing the incidence of negative emotions. Last [33]
pointed to lower levels of anxiety and depression
observed only in adolescents who were fully informed
about their disease. Also, CF patients handle well
the information that their disease may shorten their
lives. Therefore, next studies should answer the ques-
tion whether obtaining full information about pa-
tients disease decreases the level of anxiety and
depression.
According to Hodson [34] some patients with
cystic fibrosis may require psychiatric therapy in the
final stage of their disease. De Jong et al. [35] and
Britto et al. [36] proved that CF patients had lower
outcomes in physical activity when compared with
psychosocial functioning.
The review of publications showed that emo-
tions of adolescents and young adults with CF can
oscillate with different strength from the need of
independence to being dependent on others in cer-
tain situations e.g. worsened clinical status, waiting
for transplantation etc. [34, 3739]. Research indi-
cated that the feeling of having control over emo-
tions leads to the improvement of health status,
hence better quality of life. As a result, patients start
to believe that they can control negative events.
Authors own studies and publications quoted
here allow explaining low level of anxiety and de-
pression presented by young patients. Most research-
ers (according to Kazak et al. 1995 in Pilecka [6])
believe that paradoxically low level of depression
intensity in young patients results from effective con-
trol over negative emotions, which is due to well
developed managing skills, good support or mallea-
bility of their own behaviours. Depressive states may
be hidden and consciously denied. Also, self-report
questionnaires and scales utilised in the studies de-
scribe subjective picture of emotional difficulties ex-
perienced by a sick teenager rather than picture
drawn by the closest people, which are not neces-
sarily the same.
It must be underlined that disease is accompa-
nied not only by negative emotions but also positive
ones e.g. satisfaction, hope, joy, the sense and will
of life. These occur when the following needs are
fulfilled: acceptance, care, support, and the disease
is perceived as a challenge [40]. Research by Ma-
jkowicz [5] proved that the sense of life and its
purpose increased the quality of patients life and
decreased the level of negative emotions (anxiety,
depression, anger). Pilecka [6] emphasizes the fact
that disease, understood as a challenge or a problem
to be solved, results with finding the sense of life,
which becomes a chance to develop mature and in-
ternally rich personality. It seems that the following
skills: recognition and managing experiences related
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to the disease, negative emotions especially, are nec-
essary effort to overcome the illness [41, 42].
Prolonged course of disease, uncertainty of ther-
apy, irregularity resulting from the disease itself and
aggressiveness of cancer and CF therapy may affect
the sense of life and its purpose of young patients,
which are determined by the level of their hope or
its lack. Self-esteem is a result of persons own value
assessment and it becomes a critical aspect of ado-
lescents development. It may also affect young pa-
tients beliefs concerning future achievements.
Malignant disease and cystic fibrosis bring many
symptoms of physical and/ or psychic distress, which
was proven by research in that field [42, 43]. Early
detection of anxiety and depression symptoms in
patients with cancer or CF becomes priority, espe-
cially that more evidence proves an existing relation
between depression and disease progression e.g.
through endocrine and immunologic functions in
cancer [11, 44].
In the light of authors results and publications
review, which present divergent outcomes, further
studies are necessary in order to explain this phe-
nomenon. However, it may be assumed that dis-
crepant results are due to both different population
characteristics in the studied groups and the choice
of measurement tools or different measures. Most
of all, the inconsistency of outcomes proves that
relations between one persons qualities, environ-
mental conditions and the course of young mans
development are very complicated.
Conclusions
1. Anxiety and depression were observed in small
percentage of patients in both studied groups.
2. Adolescents with cancer or CF did not differ as
far as the level of anxiety and depression was
concerned. However, it cant be assured that pa-
tients were hiding disturbing symptoms (anxiety
and depression). Therefore, special care must be
delivered to those patients whose depressive and
anxiety symptoms met the norms borderline.
3.  Adolescents and young adults with high level of
anxiety are more likely to develop depressive dis-
orders, which should be considered in early de-
tection and making care plan for those patients.
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